23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      FoxO1, A2M, and TGF-β1: three novel genes predicting depression in gene X environment interactions are identified using cross-species and cross-tissues transcriptomic and miRNomic analyses

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To date, gene-environment (GxE) interaction studies in depression have been limited to hypothesis-based candidate genes, since genome-wide (GWAS)-based GxE interaction studies would require enormous datasets with genetics, environmental, and clinical variables. We used a novel, cross-species and cross-tissues “ omics” approach to identify genes predicting depression in response to stress in GxE interactions. We integrated the transcriptome and miRNome profiles from the hippocampus of adult rats exposed to prenatal stress (PNS) with transcriptome data obtained from blood mRNA of adult humans exposed to early life trauma, using a stringent statistical analyses pathway. Network analysis of the integrated gene lists identified the Forkhead box protein O1 ( FoxO1), Alpha-2-Macroglobulin ( A2M), and Transforming Growth Factor Beta 1 (TGF-β1) as candidates to be tested for GxE interactions, in two GWAS samples of adults either with a range of childhood traumatic experiences (Grady Study Project, Atlanta, USA) or with separation from parents in childhood only (Helsinki Birth Cohort Study, Finland). After correction for multiple testing, a meta-analysis across both samples confirmed six FoxO1 SNPs showing significant GxE interactions with early life emotional stress in predicting depressive symptoms. Moreover, in vitro experiments in a human hippocampal progenitor cell line confirmed a functional role of FoxO1 in stress responsivity. In secondary analyses, A2M and TGF-β1 showed significant GxE interactions with emotional, physical, and sexual abuse in the Grady Study. We therefore provide a successful ‘hypothesis-free’ approach for the identification and prioritization of candidate genes for GxE interaction studies that can be investigated in GWAS datasets.

          Related collections

          Most cited references84

          • Record: found
          • Abstract: found
          • Article: not found

          Origins and Mechanisms of miRNAs and siRNAs.

          Over the last decade, approximately 20-30 nucleotide RNA molecules have emerged as critical regulators in the expression and function of eukaryotic genomes. Two primary categories of these small RNAs--short interfering RNAs (siRNAs) and microRNAs (miRNAs)--act in both somatic and germline lineages in a broad range of eukaryotic species to regulate endogenous genes and to defend the genome from invasive nucleic acids. Recent advances have revealed unexpected diversity in their biogenesis pathways and the regulatory mechanisms that they access. Our understanding of siRNA- and miRNA-based regulation has direct implications for fundamental biology as well as disease etiology and treatment.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Gene silencing by microRNAs: contributions of translational repression and mRNA decay.

            Despite their widespread roles as regulators of gene expression, important questions remain about target regulation by microRNAs. Animal microRNAs were originally thought to repress target translation, with little or no influence on mRNA abundance, whereas the reverse was thought to be true in plants. Now, however, it is clear that microRNAs can induce mRNA degradation in animals and, conversely, translational repression in plants. Recent studies have made important advances in elucidating the relative contributions of these two different modes of target regulation by microRNAs. They have also shed light on the specific mechanisms of target silencing, which, although it differs fundamentally between plants and animals, shares some common features between the two kingdoms.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Adverse childhood experiences and the risk of depressive disorders in adulthood.

              Research examining the association between childhood abuse and depressive disorders has frequently assessed abuse categorically, thus not permitting discernment of the cumulative impact of multiple types of abuse. As previous research has documented that adverse childhood experiences (ACEs) are highly interrelated, we examined the association between the number of such experiences (ACE score) and the risk of depressive disorders. Retrospective cohort study of 9460 adult health maintenance organization members in a primary care clinic in San Diego, CA who completed a survey addressing a variety of health-related concerns, which included standardized assessments of lifetime and recent depressive disorders, childhood abuse and household dysfunction. Lifetime prevalence of depressive disorders was 23%. Childhood emotional abuse increased risk for lifetime depressive disorders, with adjusted odds ratios (ORs) of 2.7 [95% confidence interval (CI), 2.3-3.2] in women and 2.5 (95% CI, 1.9-3.2) in men. We found a strong, dose-response relationship between the ACE score and the probability of lifetime and recent depressive disorders (P<0.0001). This relationship was attenuated slightly when a history of growing up with a mentally ill household member was included in the model, but remained significant (P<0.001). The number of ACEs has a graded relationship to both lifetime and recent depressive disorders. These results suggest that exposure to ACEs is associated with increased risk of depressive disorders up to decades after their occurrence. Early recognition of childhood abuse and appropriate intervention may thus play an important role in the prevention of depressive disorders throughout the life span.
                Bookmark

                Author and article information

                Contributors
                annamaria.cattaneo@kcl.ac.uk
                Journal
                Mol Psychiatry
                Mol. Psychiatry
                Molecular Psychiatry
                Nature Publishing Group UK (London )
                1359-4184
                1476-5578
                4 January 2018
                4 January 2018
                2018
                : 23
                : 11
                : 2192-2208
                Affiliations
                [1 ]ISNI 0000 0001 2322 6764, GRID grid.13097.3c, Stress, Psychiatry and Immunology Laboratory, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, , King’s College, ; London, UK
                [2 ]GRID grid.419422.8, Biological Psychiatry Unit, , IRCCS Fatebenefratelli S. Giovanni di Dio, ; Brescia, Italy
                [3 ]ISNI 0000 0000 9497 5095, GRID grid.419548.5, Department of Translational Research in Psychiatry, , Max-Planck Institute of Psychiatry, ; Munich, Germany
                [4 ]ISNI 0000 0004 0410 2071, GRID grid.7737.4, Department of Psychology and Logopedics, , University of Helsinki, ; Helsinki, Finland
                [5 ]ISNI 0000 0001 1013 0499, GRID grid.14758.3f, National Institute for Health and Welfare, ; Helsinki, Finland
                [6 ]ISNI 0000 0004 0409 6302, GRID grid.428673.c, Folkhälsan Research Centre, ; Helsinki, Finland
                [7 ]ISNI 0000 0001 1013 0499, GRID grid.14758.3f, National Institute for Health and Welfare, ; Helsinki, Finland
                [8 ]ISNI 0000 0004 0410 2071, GRID grid.7737.4, Department of General Practice and Primary Health Care, , University of Helsinki and Helsinki University Hospital, ; Helsinki, Finland
                [9 ]ISNI 0000 0004 1757 2822, GRID grid.4708.b, Department of Pharmacological and Biomolecular Sciences, , University of Milan, ; Milan, Italy
                [10 ]ISNI 0000 0000 9950 5666, GRID grid.15485.3d, Hospital for Children and Adolescents, , Helsinki University Hospital and University of Helsinki, ; Helsinki, Finland
                [11 ]ISNI 0000 0004 4685 4917, GRID grid.412326.0, PEDEGO Research Unit, , Oulu University Hospital and University of Oulu, ; Oulu, Finland
                [12 ]Helsinki Collegium for Advanced Studies, Helsinki, Finland
                [13 ]ISNI 0000 0001 2322 6764, GRID grid.13097.3c, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, , King’s College London, ; London, UK
                [14 ]ISNI 0000 0001 0941 6502, GRID grid.189967.8, Department of Psychiatry & Behavioral Sciences, , Emory University School of Medicine, ; Atlanta, GA USA
                Author information
                http://orcid.org/0000-0001-5935-2498
                http://orcid.org/0000-0002-9132-5091
                Article
                2
                10.1038/s41380-017-0002-4
                6283860
                29302075
                7272518b-4d1c-43c8-bfb8-adf33776f64e
                © The Author(s) 2017

                Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

                History
                : 9 December 2016
                : 9 September 2017
                : 16 October 2017
                Categories
                Article
                Custom metadata
                © Springer Nature Limited 2018

                Molecular medicine
                Molecular medicine

                Comments

                Comment on this article